Gene · 10561
Papers3,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the correlation between UVB sensitivity and SLE activity: Insights into UVB-driven pathogenesis in lupus erythematosus. | J Autoimmun | 2025 | 40147218 | PubTator, text mining | PubMed |
| Determining IFI44 as a key lupus nephritis's biomarker through bioinformatics and immunohistochemistry. | Ren Fail | 2025 | 40101924 | PubTator, text mining | PubMed |
| Identification and validation of diagnostic genes IFI44 and IRF9 in insomnia-associated autoimmune uveitis. | Front Immunol | 2025 | 39958336 | PubTator, text mining | PubMed |
| Robust antiviral innate immune response and miRNA regulatory network were identified in ZIKV-infected cells: implications in the pathogenesis of ZIKV infection. | Virus Genes | 2025 | 39955676 | PubTator, text mining | PubMed |
| Identification of IFI27 involvement in the progression of neuroblastoma through bioinformatics analysis and experimental assays. | J Mol Histol | 2025 | 39915361 | PubTator, text mining | PubMed |
| PFKFB3 decreases α-ketoglutarate production while partial PFKFB3 knockdown in macrophages ameliorates arthritis in tumor necrosis factor-transgenic mice. | Int Immunopharmacol | 2025 | 39870011 | PubTator, text mining | PubMed |
| Tissue nanotransfection-based endothelial PLCγ2-targeted epigenetic gene editing rescues perfusion and diabetic ischemic wound healing. | Mol Ther | 2025 | 39863930 | PubTator, text mining | PubMed |
| Scent of COVID-19: Whole-Genome Sequencing Analysis Reveals the Role of ACE2, IFI44, and NDUFAF4 in Long-Lasting Olfactory Dysfunction. | Life (Basel) | 2025 | 39859996 | PubTator, text mining | PubMed |
| Insights into the Activation and Self-Association of Arrestin-1. | Biochemistry | 2025 | 39704710 | PubTator, text mining | PubMed |
| Analysis of the relationships between interferon-stimulated genes and anti-SSA/Ro 60 antibodies in primary Sjögren's syndrome patients via multiomics and machine learning methods. | Int Immunopharmacol | 2025 | 39577221 | PubTator, text mining | PubMed |
| Screening of Genes Associated with Immune Infiltration of Discoid Lupus Erythematosus Based on Weighted Gene Co-expression Network Analysis. | Biochem Genet | 2025 | 38451400 | PubTator, text mining | PubMed |
| α7-Nicotinic Acetylcholine Receptor Activation Modulates BV2 Microglial Plasticity via miR-21/TNF-α/NFκB in Oxygen-Glucose Deprivation/Reoxygenation. | J Mol Neurosci | 2024 | 39718716 | PubTator, text mining | PubMed |
| ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3. | BMC Med Genomics | 2024 | 39614348 | PubTator, text mining | PubMed |
| Intestinal IFNα4 promotes 15-HETE diet-induced pulmonary hypertension. | Respir Res | 2024 | 39609844 | PubTator, text mining | PubMed |
| Data sharing considerations and practice among health researchers in Africa: A scoping review. | Digit Health | 2024 | 39493630 | PubTator, text mining | PubMed |
| Novel RNA biomarkers improve discrimination of children with tuberculosis disease from those with non-TB pneumonia after in vitro stimulation. | Front Immunol | 2024 | 39391304 | PubTator, text mining | PubMed |
| Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer. | Cancer Res | 2024 | 39356622 | PubTator, text mining | PubMed |
| Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19. | Viruses | 2024 | 39339845 | PubTator, text mining | PubMed |
| Genome-wide analysis reveals the MORC3-mediated repression of PD-L1 expression in head and neck cancer. | Front Cell Dev Biol | 2024 | 39329063 | PubTator, text mining | PubMed |
| Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren's Syndrome. | J Inflamm Res | 2024 | 39219820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10561/papers?page=5